Advanced Filters
noise

myopia Clinical Trials

A listing of myopia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 88 clinical trials
Y Ying Li, MD.Ph.D.

Myopia Control Combined PBM With Myopic Defocus Lens in Children

To study the efficacy of myopi control with two methods: low lever red light and peripheral defocus spectacles with four groups and design with prospective, double-blind, randimized, and with control for 6 month.

6 - 13 years of age Both Phase N/A
H HUADONG Ai, OD

Myopia Preventing With Distance-image Screen

This study is for testing the efficacy and safety of distance-image screens for preventing myopia in children for 12 month. Each subjects would be asked to paired test the ocular parameters between before and after 12-month distance-image screens.

6 - 12 years of age Both Phase N/A
J Jenny QIU, MD

Slow Myopia Progression With Different Irradiance Light

It is a prospective clinical control study on red light control myopia with specail design spectacles for 75 children in 3 groups. Study Groups with two different powers of 0.6 mW and 1.2 mW at wavelength of 650nm. The control group is to wear the same brand and design spectalces …

6 - 12 years of age Both Phase N/A
W Wolf A. Lagrèze, Prof.

Low-dose Atropine for Myopia Control in Children

Myopia (nearsightedness) is the most common eye disorder. Only second to age, it is the main risk factor for major degenerative eye diseases such as glaucoma, macular degeneration or retinal detachment. Their risk increases with the degree of myopia. Hence, prevention of myopia and slowing its progression is of high …

8 - 12 years of age Both Phase 2/3
J Jiunn-Liang Chen, MD

A Study of SHJ002 Sterile Ophthalmic Solution for Myopia Control

The objective of this study is to explore the safety and efficacy of SHJ002 Sterile Ophthalmic Solution relative to atropine in myopia control SHJ002 is an antisense oligonucleotide to neutralize a specific microRNA.

3 - 12 years of age Both Phase 2
L Linlin Du

Double Helix Design Defocus Lens Spectacle (RACE) for Myopia Control

This study uses 1.585 double helix defocus lens PC lenses with a unique optical design that includes a globally coherent visible area and complementary left and right helices that can form clear images. In addition, the helical arrangement and reduced slit area can generate defocusing signals, inhibiting the development of …

6 - 13 years of age Both Phase N/A
X Xiangui He, MD

Low Concentration Atropine in the Prevention of Myopia in Children.

This double-blind, randomized controlled clinical study is to evaluate the effectiveness and safety of low concentration atropine in preventing myopia in pre-myopia children, and to explore whether there is a dose effect relationship between different concentrations of atropine in preventing myopia.

6 - 9 years of age Both Phase N/A

Clinical Study of Light Therapy to Control Myopia Progression in Children

Low-lever red light therapy (LLLT) has been used to control myopia progression in China for a few years besides amblyopia therapy for a few decades. This study is to test the efficacy of PBM therapy to myopia children as well as to compare two types of PBM therapy to control …

6 - 16 years of age Both Phase N/A
S Shuxian Zhang

Effects of Different Designs of Orthokeratology Lens on Myopia Control and Visual Quality

This study was aimed to evaluate the effects of different Orthokeratology,including the size of central optical zone and the height of peripheral reverse curve, on myopia control and visual quality.

8 - 13 years of age Both Phase N/A
X XiangLin Zhang

Community Intervention and Demonstration Area Construction

The objective of this intervention study was to understand the visual health status of nearly one million children and adolescents in ten provinces in China, and then to conduct intervention and evaluate the effect of intervention measures with the development of myopia as the outcome indicator. The study will be …

- 100 years of age Both Phase N/A

Rewrite in simple language using AI